Answers are grounded in this paper and cite their sources.
The secretory pathway enables the precise intracellular delivery of a vast variety of proteins; however, the mechanisms of compartment specific targeting remain poorly understood. The nervous system is particularly vulnerable to defects in intracellular transport because of the specific functional and structural characteristics of neural cells, especially during development. Here, we focus on ER-to-Golgi transport, the first step of secretory pathway, in which cargo receptors recognize a specific repertoire of proteins and enable their COPII (coat protein complex II) mediated transport. Mutations in such receptors impair the delivery of their specific cargoes rather than the secretory pathway as a whole. In this case, cargo proteins may remain genetically intact and continue to be synthesized, but become functionally unavailable due to their mislocalization. The clinical phenotypes caused by pathogenic variants of genes encoding such proteins therefore depend largely on the loss of cargo protein function, with potentially profound consequences for nervous system development. In this Perspective, we propose a novel concept of cargo-receptor-dependent disorders. We discuss pathogenic variants in established cargo receptors, such as CLN8 and, LMAN2L and TMED10, as examples of this mechanism. As supporting evidence, we consider IER3IP1, a protein involved in ER-to-Golgi trafficking that has not been proven to be a cargo receptor but whose dysfunction leads to a similar phenotype. Identification and characterization of cargo receptors, their targets and auxiliary proteins will expand our understanding of the fundamental principles of intracellular transport and reveal previously unrecognized mechanisms of inherited diseases and potential therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Medyanik et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: